Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
IMPAX LABS Add to My Watchlist (NSDQ: IPXL) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Impax 13.66 +0.02 (+0.15%) 358,109
30831 Huntwood Avenue
Hayward, CA 94544 US
(510) 476-2000
(510) 471-3200 fax
www.impaxlabs.com
CEO Dr. Larry Hsu, Ph.D.
Auditor Grant Thornton, LLP
Exchange Traded NQ
ISIN Number US45256B1017
CIK Number 1003642
NAICS Code 325412
Business Summary
A technology-based pharmaceutical company. The Company has two reportable segments, Global Pharmaceuticals Division and Impax Pharmaceutical Division.
Number of Employees 768
Share Fundamentals
Market Cap 845.21M
Shares Outstanding 61.87M
Float 54.69M
Short Interest 2.31M
Financial Strength
Revenue (TTM) $226,970,000
Earnings (TTM) $23,599,000
Quick Ratio 1.5:1
Current Ratio 2.2:1
Total Debt/Equity 0:1
Profitability
Gross Margin 70.3%
EBITDA Margin 24.1%
Profit Margin 15.5%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs